Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Heron Therapeutics (HRTX) Inventory Average (2016 - 2026)

Heron Therapeutics filings provide 11 years of Inventory Average readings, the most recent being $92.6 million for Q1 2026.

  • On a quarterly basis, Inventory Average rose 68.3% to $92.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $92.6 million, a 68.3% increase, with the full-year FY2025 number at $73.0 million, up 53.15% from a year prior.
  • Inventory Average hit $92.6 million in Q1 2026 for Heron Therapeutics, up from $81.4 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $92.6 million in Q1 2026 to a low of $21.1 million in Q1 2024.
  • Median Inventory Average over the past 5 years was $53.3 million (2023), compared with a mean of $53.6 million.
  • Biggest five-year swings in Inventory Average: crashed 60.42% in 2024 and later soared 202.34% in 2025.
  • Heron Therapeutics' Inventory Average stood at $53.4 million in 2022, then dropped by 21.25% to $42.1 million in 2023, then increased by 17.82% to $49.6 million in 2024, then soared by 64.23% to $81.4 million in 2025, then increased by 13.83% to $92.6 million in 2026.
  • The last three reported values for Inventory Average were $92.6 million (Q1 2026), $81.4 million (Q4 2025), and $71.5 million (Q3 2025) per Business Quant data.